申请人:Ellies Debra
公开号:US20100249171A1
公开(公告)日:2010-09-30
The present invention provides a method of reducing body weight in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I:
In Formula I, R
1
is H, C
1-6
alkyl, or C
1-6
alkyl-aryl. Each of R
2
and R
4
of Formula I are independently H, halogen, C
1-6
alkyl, C
1-6
haloalkyl, C
2-6
alkenyl, C
2-6
alkynyl, C
1-6
haloalkoxy, —OR
2a
, —SR
2a
, —C(O)R
2a
, —C(O)OR
2a
, —C(O)NR
2a
R
2b
, —NR
2a
R
2b
, C
1-6
alkyl-NR
2a
R
2b
, —N(R
2a
)C(O)R
2b
, —N(R
2a
)C(O)OR
2b
, —N(R
2a
)C(O)NR
2a
R
2b
, —OP(O)(OR
2a
)
2
, —S(O)
2
OR
2a
, —S(O)
2
NR
2a
R
2b
, —CN, —NO
2
, cycloalkyl, heterocycloalkyl, aryl or heteroaryl. Each of R
2a
and R
2b
of Formula I are independently H, C
1-6
alkyl, C
1-10
heteroalkyl or C
1-6
alkyl-aryl. R
3
of Formula I is absent, C
1-6
alkyl or N-oxide. The compounds include the salts, hydrates and isomers thereof. The present invention also provides methods for the treatment of obesity and disorders related to obesity and higher than recommended percentage body fat, such as type II diabetes.